Prognostic factors affecting overall survival, univariate analysis
| Variables . | Unfavorable factor . | Univariate . | |
|---|---|---|---|
| Relative risk (95% CI) . | P . | ||
| CD5 status | Positive | 1.60 (1.20-2.13) | .0012 |
| Age | > 60 y | 2.00 (1.52-2.63) | .0000007 |
| Performance status | 2-4 | 3.54 (2.72-4.61) | < .0000001 |
| LDH | > Normal | 3.14 (2.41-4.10) | < .0000001 |
| Stage | III/IV | 2.90 (2.23-3.77) | < .0000001 |
| Extranodal disease | > 1 site | 2.58 (1.99-3.35) | < .0000001 |
| IPI | HI/H | 3.95 (3.06-5.10) | < .0000001 |
| B symptoms | Present | 2.98 (2.30-3.85) | < .0000001 |
| Variables . | Unfavorable factor . | Univariate . | |
|---|---|---|---|
| Relative risk (95% CI) . | P . | ||
| CD5 status | Positive | 1.60 (1.20-2.13) | .0012 |
| Age | > 60 y | 2.00 (1.52-2.63) | .0000007 |
| Performance status | 2-4 | 3.54 (2.72-4.61) | < .0000001 |
| LDH | > Normal | 3.14 (2.41-4.10) | < .0000001 |
| Stage | III/IV | 2.90 (2.23-3.77) | < .0000001 |
| Extranodal disease | > 1 site | 2.58 (1.99-3.35) | < .0000001 |
| IPI | HI/H | 3.95 (3.06-5.10) | < .0000001 |
| B symptoms | Present | 2.98 (2.30-3.85) | < .0000001 |
CI indicates confidence interval.